(Q34777721)

4 August 2017

1 reference

title

Vitamin E and neurodegenerative disorders associated with oxidative stress (English)

1 reference

4 August 2017

1 reference

1

D Allan Butterfield

1 reference

4 August 2017

Alessandra Castegna

2

1 reference

4 August 2017

Jennifer Drake

series ordinal

3

1 reference

4 August 2017

Giovanni Scapagnini

series ordinal

4

1 reference

4 August 2017

Vittorio Calabrese

series ordinal

5

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

Nutritional Neuroscience

1 reference

4 August 2017

5

1 reference

4 August 2017

4

1 reference

4 August 2017

229-239

1 reference

Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.

4 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Recent advances in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E: non-antioxidant roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E and other antioxidants in neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E in extrapyramidal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E in the treatment of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

The alpha-tocopherol and phospholipid fatty acid content of rat liver subcellular membranes in vitamin E and selenium deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Medical utility of apoe allele determination in assessing the need for antioxidant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Oxidative stress and antioxidant therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

ON THE EXISTENCE OF A HITHERTO UNRECOGNIZED DIETARY FACTOR ESSENTIAL FOR REPRODUCTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Case-control study of early life dietary factors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Environmental risk factors in MS: a case-control study in Moscow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Role of free radicals and catalytic metal ions in human disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin A and E levels are normal in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Chemical neurotoxins as denervation tools in neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Oxidative stress effect on the activation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Trial of d-alpha-tocopherol in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Lou Gehrig and amyotrophic lateral sclerosis. Is vitamin E to be revisited?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Dietary antioxidants and Parkinson disease. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Apolipoprotein E alleles as risk factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Evidence for increased lipid peroxidation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10284150290028954

10.1080/10284150290028954

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference